Harmon DTC
Company profile on P2PMarketData. Harmon DTC is a healthcare services company based in Purchase, NY, founded in 2026. It is raising on DealMaker now.
Harmon DTC is a telehealth company based in Purchase, New York, operating as Harmon.Health. It offers doctor-prescribed GLP-1 weight-loss treatment, including compounded semaglutide and tirzepatide, that is prescribed by licensed U.S. physicians after an online visit and shipped from a licensed U.S. pharmacy. The service is delivered on a subscription basis, with one monthly price covering the visit, medication, shipping, and ongoing support.
Frequently asked questions about Harmon DTC
What is Harmon DTC's valuation?
Harmon DTC had an indicative valuation of $20M in its 2026 funding round.
Is Harmon DTC profitable?
Harmon DTC broke even, reporting no net income or loss for fiscal year 2024.
Can I invest in Harmon DTC?
Yes. Harmon DTC has an open crowdfunding deal on DealMaker.
When was Harmon DTC founded?
Harmon DTC was founded in January 2026.
Where is Harmon DTC based?
Harmon DTC is headquartered in Purchase, New York, United States, and is incorporated in Nevada, United States.
What industry is Harmon DTC in?
Harmon DTC operates in the Healthcare Services industry within the Healthcare sector.